Logo image of MATV

MATIV HOLDINGS INC (MATV) Stock Fundamental Analysis

NYSE:MATV - US8085411069 - Common Stock

12.45 USD
-0.12 (-0.95%)
Last: 9/2/2025, 3:29:52 PM
Fundamental Rating

3

Overall MATV gets a fundamental rating of 3 out of 10. We evaluated MATV against 83 industry peers in the Chemicals industry. MATV may be in some trouble as it scores bad on both profitability and health. MATV is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

MATV had positive earnings in the past year.
MATV had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: MATV reported negative net income in multiple years.
Each year in the past 5 years MATV had a positive operating cash flow.
MATV Yearly Net Income VS EBIT VS OCF VS FCFMATV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M -200M -300M

1.2 Ratios

MATV has a Return On Assets of -21.89%. This is amonst the worse of the industry: MATV underperforms 85.54% of its industry peers.
MATV's Return On Equity of -109.10% is on the low side compared to the rest of the industry. MATV is outperformed by 86.75% of its industry peers.
Looking at the Return On Invested Capital, with a value of 1.46%, MATV is doing worse than 69.88% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for MATV is below the industry average of 6.34%.
Industry RankSector Rank
ROA -21.89%
ROE -109.1%
ROIC 1.46%
ROA(3y)-4.64%
ROA(5y)-1%
ROE(3y)-13%
ROE(5y)-2.64%
ROIC(3y)1.6%
ROIC(5y)3.28%
MATV Yearly ROA, ROE, ROICMATV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20 -30

1.3 Margins

The Operating Margin of MATV (1.68%) is worse than 73.49% of its industry peers.
In the last couple of years the Operating Margin of MATV has declined.
The Gross Margin of MATV (17.66%) is worse than 69.88% of its industry peers.
In the last couple of years the Gross Margin of MATV has declined.
Industry RankSector Rank
OM 1.68%
PM (TTM) N/A
GM 17.66%
OM growth 3Y-31.88%
OM growth 5Y-30.13%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-7.12%
GM growth 5Y-8.31%
MATV Yearly Profit, Operating, Gross MarginsMATV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 30

3

2. Health

2.1 Basic Checks

MATV has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for MATV has been increased compared to 1 year ago.
The number of shares outstanding for MATV has been increased compared to 5 years ago.
Compared to 1 year ago, MATV has a worse debt to assets ratio.
MATV Yearly Shares OutstandingMATV Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
MATV Yearly Total Debt VS Total AssetsMATV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

Based on the Altman-Z score of 1.29, we must say that MATV is in the distress zone and has some risk of bankruptcy.
MATV has a worse Altman-Z score (1.29) than 73.49% of its industry peers.
The Debt to FCF ratio of MATV is 24.06, which is on the high side as it means it would take MATV, 24.06 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of MATV (24.06) is comparable to the rest of the industry.
A Debt/Equity ratio of 2.65 is on the high side and indicates that MATV has dependencies on debt financing.
MATV's Debt to Equity ratio of 2.65 is on the low side compared to the rest of the industry. MATV is outperformed by 85.54% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.65
Debt/FCF 24.06
Altman-Z 1.29
ROIC/WACC0.15
WACC9.71%
MATV Yearly LT Debt VS Equity VS FCFMATV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.3 Liquidity

MATV has a Current Ratio of 2.37. This indicates that MATV is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 2.37, MATV is in the better half of the industry, outperforming 65.06% of the companies in the same industry.
MATV has a Quick Ratio of 1.21. This is a normal value and indicates that MATV is financially healthy and should not expect problems in meeting its short term obligations.
MATV has a Quick ratio of 1.21. This is comparable to the rest of the industry: MATV outperforms 46.99% of its industry peers.
Industry RankSector Rank
Current Ratio 2.37
Quick Ratio 1.21
MATV Yearly Current Assets VS Current LiabilitesMATV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

4

3. Growth

3.1 Past

MATV shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -43.75%.
Measured over the past years, MATV shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -29.46% on average per year.
MATV shows a decrease in Revenue. In the last year, the revenue decreased by -0.36%.
Measured over the past years, MATV shows a quite strong growth in Revenue. The Revenue has been growing by 14.14% on average per year.
EPS 1Y (TTM)-43.75%
EPS 3Y-38.46%
EPS 5Y-29.46%
EPS Q2Q%-2.94%
Revenue 1Y (TTM)-0.36%
Revenue growth 3Y11.22%
Revenue growth 5Y14.14%
Sales Q2Q%0.31%

3.2 Future

MATV is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 27.84% yearly.
MATV is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.28% yearly.
EPS Next Y3.65%
EPS Next 2Y31.74%
EPS Next 3Y27.84%
EPS Next 5YN/A
Revenue Next Year-0.05%
Revenue Next 2Y1.38%
Revenue Next 3Y1.03%
Revenue Next 5Y1.28%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
MATV Yearly Revenue VS EstimatesMATV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 500M 1B 1.5B 2B
MATV Yearly EPS VS EstimatesMATV Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3

4

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 27.67 indicates a quite expensive valuation of MATV.
Compared to the rest of the industry, the Price/Earnings ratio of MATV is on the same level as its industry peers.
The average S&P500 Price/Earnings ratio is at 27.13. MATV is around the same levels.
With a Price/Forward Earnings ratio of 11.57, the valuation of MATV can be described as very reasonable.
Based on the Price/Forward Earnings ratio, MATV is valued a bit cheaper than 75.90% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.76, MATV is valued a bit cheaper.
Industry RankSector Rank
PE 27.67
Fwd PE 11.57
MATV Price Earnings VS Forward Price EarningsMATV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of MATV indicates a somewhat cheap valuation: MATV is cheaper than 62.65% of the companies listed in the same industry.
79.52% of the companies in the same industry are more expensive than MATV, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 14.76
EV/EBITDA 9.69
MATV Per share dataMATV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
A more expensive valuation may be justified as MATV's earnings are expected to grow with 27.84% in the coming years.
PEG (NY)7.59
PEG (5Y)N/A
EPS Next 2Y31.74%
EPS Next 3Y27.84%

4

5. Dividend

5.1 Amount

MATV has a Yearly Dividend Yield of 3.25%.
MATV's Dividend Yield is rather good when compared to the industry average which is at 3.44. MATV pays more dividend than 80.72% of the companies in the same industry.
MATV's Dividend Yield is a higher than the S&P500 average which is at 2.32.
Industry RankSector Rank
Dividend Yield 3.25%

5.2 History

The dividend of MATV decreases each year by -25.76%.
MATV has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)-25.76%
Div Incr Years0
Div Non Decr Years0
MATV Yearly Dividends per shareMATV Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

5.3 Sustainability

The earnings of MATV are negative and hence is the payout ratio. MATV will probably not be able to sustain this dividend level.
DP-4.88%
EPS Next 2Y31.74%
EPS Next 3Y27.84%
MATV Yearly Income VS Free CF VS DividendMATV Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M -200M -300M

MATIV HOLDINGS INC

NYSE:MATV (9/2/2025, 3:29:52 PM)

12.45

-0.12 (-0.95%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)08-06 2025-08-06/amc
Earnings (Next)11-04 2025-11-04/amc
Inst Owners91.1%
Inst Owner ChangeN/A
Ins Owners0.92%
Ins Owner Change29.3%
Market Cap680.64M
Analysts85.71
Price Target15.81 (26.99%)
Short Float %1.22%
Short Ratio0.96
Dividend
Industry RankSector Rank
Dividend Yield 3.25%
Yearly Dividend0.4
Dividend Growth(5Y)-25.76%
DP-4.88%
Div Incr Years0
Div Non Decr Years0
Ex-Date08-29 2025-08-29 (0.1)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)27.48%
Min EPS beat(2)-24.78%
Max EPS beat(2)79.74%
EPS beat(4)2
Avg EPS beat(4)43.73%
Min EPS beat(4)-25.13%
Max EPS beat(4)145.1%
EPS beat(8)5
Avg EPS beat(8)42.39%
EPS beat(12)6
Avg EPS beat(12)28.29%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)1.53%
Min Revenue beat(2)1.06%
Max Revenue beat(2)2%
Revenue beat(4)2
Avg Revenue beat(4)-2.71%
Min Revenue beat(4)-7.08%
Max Revenue beat(4)2%
Revenue beat(8)2
Avg Revenue beat(8)-3.46%
Revenue beat(12)3
Avg Revenue beat(12)-3.27%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)19.23%
PT rev (3m)19.23%
EPS NQ rev (1m)-12.9%
EPS NQ rev (3m)-12.9%
EPS NY rev (1m)2.44%
EPS NY rev (3m)0.8%
Revenue NQ rev (1m)-3.85%
Revenue NQ rev (3m)-3.97%
Revenue NY rev (1m)0.59%
Revenue NY rev (3m)0.59%
Valuation
Industry RankSector Rank
PE 27.67
Fwd PE 11.57
P/S 0.35
P/FCF 14.76
P/OCF 6.58
P/B 1.63
P/tB N/A
EV/EBITDA 9.69
EPS(TTM)0.45
EY3.61%
EPS(NY)1.08
Fwd EY8.64%
FCF(TTM)0.84
FCFY6.77%
OCF(TTM)1.89
OCFY15.19%
SpS35.99
BVpS7.62
TBVpS-3.43
PEG (NY)7.59
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -21.89%
ROE -109.1%
ROCE 1.85%
ROIC 1.46%
ROICexc 1.55%
ROICexgc 2.41%
OM 1.68%
PM (TTM) N/A
GM 17.66%
FCFM 2.34%
ROA(3y)-4.64%
ROA(5y)-1%
ROE(3y)-13%
ROE(5y)-2.64%
ROIC(3y)1.6%
ROIC(5y)3.28%
ROICexc(3y)1.67%
ROICexc(5y)3.41%
ROICexgc(3y)3.34%
ROICexgc(5y)7.27%
ROCE(3y)2.03%
ROCE(5y)4.15%
ROICexcg growth 3Y-27.26%
ROICexcg growth 5Y-28.59%
ROICexc growth 3Y-23.81%
ROICexc growth 5Y-28.43%
OM growth 3Y-31.88%
OM growth 5Y-30.13%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-7.12%
GM growth 5Y-8.31%
F-Score4
Asset Turnover0.95
Health
Industry RankSector Rank
Debt/Equity 2.65
Debt/FCF 24.06
Debt/EBITDA 6.29
Cap/Depr 40.18%
Cap/Sales 2.91%
Interest Coverage 0.38
Cash Conversion 58.88%
Profit Quality N/A
Current Ratio 2.37
Quick Ratio 1.21
Altman-Z 1.29
F-Score4
WACC9.71%
ROIC/WACC0.15
Cap/Depr(3y)43.24%
Cap/Depr(5y)43.56%
Cap/Sales(3y)2.94%
Cap/Sales(5y)2.93%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-43.75%
EPS 3Y-38.46%
EPS 5Y-29.46%
EPS Q2Q%-2.94%
EPS Next Y3.65%
EPS Next 2Y31.74%
EPS Next 3Y27.84%
EPS Next 5YN/A
Revenue 1Y (TTM)-0.36%
Revenue growth 3Y11.22%
Revenue growth 5Y14.14%
Sales Q2Q%0.31%
Revenue Next Year-0.05%
Revenue Next 2Y1.38%
Revenue Next 3Y1.03%
Revenue Next 5Y1.28%
EBIT growth 1Y27.41%
EBIT growth 3Y-24.24%
EBIT growth 5Y-20.26%
EBIT Next Year4232.08%
EBIT Next 3Y267.29%
EBIT Next 5YN/A
FCF growth 1Y-61.9%
FCF growth 3Y26.86%
FCF growth 5Y-20.85%
OCF growth 1Y-49.24%
OCF growth 3Y17.73%
OCF growth 5Y-9.97%